Izzar Rachid
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Izzar Rachid. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BIIB | Head of Global Product Strat. | Sale | 2,223 | $135.00 | $300,105 | Jul 8, 2025 |
| BIIB | Head of Global Product Strat. | Tax Withholding | 445 | $142.54 | $63,430 | Feb 10, 2025 |
| BIIB | Head of Global Product Strat. | Tax Withholding | 565 | $141.35 | $79,863 | Feb 7, 2025 |
| BIIB | Head of Global Product Strat. | Option Exercise | 1,370 | — | — | Feb 16, 2024 |
| BIIB | Head of Global Product Strat. | Option Exercise | 1,515 | — | — | Feb 9, 2024 |
| BIIB | Head of Global Product Strat. | Tax Withholding | 621 | $240.30 | $149,226 | Feb 8, 2024 |
| BIIB | Head of Global Product Strat. | Tax Withholding | 244 | $284.85 | $69,503 | Jun 30, 2023 |
| BIIB | Head of Global Product Strat. | Option Exercise | 767 | — | — | Feb 17, 2023 |
| BIIB | Head of Global Product Strat. | Option Exercise | 453 | — | — | Feb 10, 2023 |
| BIIB | Head of Alzheimer's Disease | Award / Grant | 1,783 | — | — | Jan 25, 2023 |
| BIIB | Head of Alzheimer's Disease | Tax Withholding | 189 | $298.90 | $56,492 | Dec 2, 2022 |
| BIIB | Head of Alzheimer's Disease | Option Exercise | 504 | — | — | Jul 1, 2022 |
| BIIB | Head of Alzheimer's Disease | Tax Withholding | 175 | $209.79 | $36,713 | Feb 18, 2022 |
| BIIB | Head of Alzheimer's Disease | Option Exercise | 351 | — | — | Feb 12, 2022 |
| BIIB | Head of Alzheimer's Disease | Tax Withholding | 165 | $228.52 | $37,706 | Dec 2, 2021 |